Futura Medical (LON:FUM) Trading 13.3% Higher – What’s Next?

Shares of Futura Medical plc (LON:FUM) traded up 13.3% during trading on Wednesday . The stock traded as high as GBX 1.43 and last traded at GBX 1.25. 652,218 shares were traded during mid-day trading, a decline of 90% from the average session volume of 6,444,076 shares. The stock had previously closed at GBX 1.10.

Futura Medical Stock Up 13.3%

The business has a 50-day moving average price of GBX 1.25 and a two-hundred day moving average price of GBX 2.22. The firm has a market cap of £7.24 million, a PE ratio of -0.60 and a beta of 0.21.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.